News in brief

Kaneka receives Canadian NPN for Floradapt Cardio

By Stephen Daniells

- Last updated on GMT

© Getty Images / Moussa81
© Getty Images / Moussa81

Related tags Probiotics Canada

Health Canada’s Natural Health Products Directorate (NHPD) has issued a Class III approval for Kaneka’s Floradapt Cardio probiotic.

Identified by the Natural Product Number (NPN) 80096187, Floradapt Cardio​ contains Lactobacillus plantarum​ KABP-011, KABP-012, and KABP-013.

“With this approval from Health Canada, we are providing dietary supplement companies an innovative way to engage the cardiovascular market,”​ said Mike Kolifrath, Vice President, Sales and Marketing of the Probiotics Division at Kaneka.

The product’s NPN allows for the following claims in Canada (the claims are not valid for the USA):

• Helps to reduce levels of total cholesterol in men and women with hypercholesterolemia.

• Helps support healthy cholesterol level in hypercholesterolemic patients

• Supports cardiovascular health by contributing to healthy serum cholesterol in hypercholesterolemic patients

• Helps support intestinal / gastrointestinal health

• Could promote a favorable gut flora

• Source of probiotics

Related news

Related products

show more

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Content provided by Aker BioMarine | 14-Feb-2024 | White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...

Latest Research Findings on Omega-3s for Heart Health

Latest Research Findings on Omega-3s for Heart Health

Content provided by GC Rieber VivoMega™ | 12-Feb-2024 | White Paper

According to Grandview Research, the global omega-3 market is a $2.62 billion market and is one of the fastest-growing segments in the dietary supplement...

Related suppliers

Follow us

Products

View more

Webinars